Delivery Order SPE2DB20D7066-SPE2DB25FC3HG
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $6,249.17 firm fixed-price delivery order (Contract No. 4569433326) for Nora-Be Tablet 168S from the Defense Logistics Agency's Medical Supply Chain on September 13, 2025, with completion due by October 9, 2025. This is a non-set-aside, competitively awarded contract representing a child order under a larger indefinite delivery contract vehicle. The delivery order was placed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,468.88 to AmerisourceBergen Drug Corp for NORA-BE Tablet 28S pharmaceutical products. This firm fixed-price delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made without a set-aside designation through open competition, reflecting...
- The Defense Logistics Agency awarded a $85,380 firm fixed price delivery order to Amerisourcebergen Drug Corporation for NORA-BE tablets. The order is being fulfilled under the prime contractor's corporate office division from its facility in Conshohocken, Pennsylvania. The delivery order was issued on June 23, 2023 with work to be completed by June 26, 2023 to supply pharmaceutical products in support of the Defense Logistics Agency's medical supply chain requirements. No subcontractors or...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,063.20 firm fixed-price delivery order is for the supply of NORA-BE TABLET 28S medical products, with an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,107.28, is for the supply of 4566573283 NORA-BE TABLET 28S medication. The award has an ultimate completion date of December 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,589.30 by the Defense Logistics Agency (DLA) on September 10, 2025. The order, which is firm fixed price and non-competitive set-aside, calls for delivery of NURTEC ODT 75 mg tablets in quantities of 8 units, with a completion date of September 11, 2025. The place of performance is the vendor's corporate office location in Conshohocken, PA....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,177.31 by the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. The contract is classified as a child order under a larger vehicle and represents a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 26, 2025. No set-aside designation was utilized for this award. The vendor's place...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,051.52 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for ultimate completion on July 15,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $3,798.36 from the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,762.72 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 14, 2025, and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC3HGDelivery Order
The Defense Logistics Agency awarded a $2,913.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for NORA-BE Tablet 28S pharmaceutical products. This non-set-aside contract, which serves the place of performance in Conshohocken, Pennsylvania, is scheduled for completion by May 14, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a substantial federal contracting portfolio focused on supporting military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency and other government healthcare customers worldwide. This delivery order exemplifies the company's role as a critical vendor in the federal medical supply chain, fulfilling individual pharmaceutical requirements through competitively awarded, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 5/13/25 |